Breast Cancer | Hope Rugo, MD

Data + Perspectives: Clinical Investigators Explore the Biology Underlying the Role of PARP Inhibition in the Management of Common Cancers — Faculty Presentation 2: PARP inhibitors for breast cancer — Dr Rugo. CME information and select publications